v3.25.1
CONSOLIDATED BALANCE SHEETS (FY) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
ASSETS      
Property and equipment, net $ 33,128 $ 33,489 $ 34,744
Asset held for sale, net 10,362 10,334 10,593
Cash 455 582 953
Restricted cash 2,601 2,890 3,231
Accounts receivable, net of allowances of $141 and $2,040 3,640 3,362 1,403
Prepaid expenses and other 410 633 613
Notes receivable 369 369 1,044
Intangible assets-bed licenses 2,471 2,471 2,471
Intangible assets - lease rights, net 65 69 87
Right-of-use operating lease assets 2,043 2,154 2,556
Goodwill 1,585 1,585 [1] 1,585 [1]
Straight-line rent receivable 2,150 2,527 2,901
Total assets 59,279 60,465 62,181
LIABILITIES AND EQUITY      
Senior debt, net 33,989 34,287 35,885
Debt related to asset held for sale, net 8,146 8,234 7,970
Bonds, net 5,853 5,851 5,991
Other debt, net 1,171 1,349 889
Accounts payable 5,115 3,695 2,493
Accrued expenses 5,418 5,414 4,060
Operating lease obligation 2,348 2,472 2,917
Other liabilities 1,398 2,082 1,791
Total liabilities 63,438 63,384 61,996
Commitments and Contingencies (Note 13)
Stockholders' equity:      
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 1,890 and 1,850 shares issued and 1,879 and 1,839 shares outstanding at December 31, 2024 and December 31, 2023, respectively 63,798 63,173 63,059
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:      
Accumulated deficit (86,985) (85,120) (81,902)
Total stockholders' (deficit) equity (4,159) (2,919) 185
Total liabilities and stockholders' (deficit) equity 59,279 60,465 62,181
Series A Preferred Stock      
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:      
Preferred stock 426 426 426
Series B Preferred Stock      
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows:      
Preferred stock $ 18,602 $ 18,602 $ 18,602
[1] The Company does not amortize indefinite-lived intangibles, which consist of separable bed licenses and goodwill.